Dr. James Michael Pluda M.D.
Oncologist | Medical Oncology
1613 Harvest Moon Ln Hatfield PA, 19440About
Dr. James Pluda is an oncologist practicing in Hatfield, PA. Dr. Pluda specializes in the care and treatment of patients with cancer. As an oncologist, Dr. Pluda manages and oversees the treatment of a cancer patient after he or she has been diagnosed with the disease. Oncologists will care for their patients throughout the course of the disease. Types of oncologists include medical oncologists, surgical oncologists, radiation oncologists, gynecologic oncologists, pediatric oncologists and hematologist oncologists.
Education and Training
Chicago Medical School at Rosalind Franklin University of Medicine & Science 1980
Provider Details
Expert Publications
Data provided by the National Library of Medicine- O6-benzylguanine: a clinical trial establishing the biochemical modulatory dose in tumor tissue for alkyltransferase-directed DNA repair.
- A pharmacokinetically guided Phase II study of carboxyamido-triazole in androgen-independent prostate cancer.
- Phase II trial of the antiangiogenic agent thalidomide in patients with recurrent high-grade gliomas.
- High-performance liquid chromatography with mass spectrometry detection for quantitating COL-3, a chemically modified tetracycline, in human plasma.
- Phase II evaluation of thalidomide in patients with metastatic breast cancer.
- Clinical trials referral resource. Current clinical trials administering the antiangiogenesis agent SU5416.
- Phase I clinical trial of oral COL-3, a matrix metalloproteinase inhibitor, in patients with refractory metastatic cancer.
- Reversible sideroblastic anemia associated with the tetracycline analogue COL-3.
- Drug-induced lupus associated with COL-3: report of 3 cases.
- A randomized phase II trial of thalidomide, an angiogenesis inhibitor, in patients with androgen-independent prostate cancer.
- Approaches to preclinical screening of antiangiogenic agents.
- A pilot study of cidofovir in patients with kaposi sarcoma.
- Therapy of AIDS and AIDS-associated neoplasms.
- Using positron emission tomography 2-deoxy-2-[18F]fluoro-D-glucose, 11CO, and 15O-water for monitoring androgen independent prostate cancer.
- Factors involved in the pharmacokinetics of COL-3, a matrix metalloproteinase inhibitor, in patients with refractory metastatic cancer: clinical and experimental studies.
Dr. James Michael Pluda M.D.'s Practice location
Dr. James Michael Pluda M.D.'s reviews
Write ReviewRecommended Articles
- New Screening Method Can Detect Tumor-Derived DNA in Women with Early Ovarian Cancer
Diagnostic issues have plagued ovarian cancer treatment efforts. Physical symptoms of ovarian cancer are initially vague (primarily mild common gastric and urinary problems). Surgical biopsy is its primary diagnostic focus.Scientists have relied on DNA alterations found in biopsied tumor samples to...
- What are the Signs and Symptoms of Pancreatic Cancer?
Do you want to know the signs and symptoms of pancreatic cancer? Symptoms of this disease typically depend on the location of the cancer. Please note that those who have pancreatic cancer typically see their symptoms manifest only after the cancer grows beyond the pancreas itself. This makes it a...
- Why Ovarian Cancer is Difficult to Detect Early
All too often we hear the term “the silent killer” when describing ovarian cancer. This term has come from the false belief that ovarian cancer is a disease without any warning signs and without much research. However, there is quite a lot of research, in fact, that confirms that most women who...
- How #Cancerland Changed New York Fashion Week
New York Fashion Week is a prestigious event that is held every year in the months of February and September. It shows off the latest fashion collections from renown designers, exhibited by the world’s most successful models. This year, AnoOno came together with #Cancerland, a U.S. non-profit...
- What are the Stages of Melanoma?
Melanoma is a type of skin cancer which affects the melanocytes of the skin, which give skin its color. It is a malignant tumor and may develop from an existing mole or as a new mole. It being malignant means that it is a dangerous condition and can lead to death. The common sites they affect are...
- Women Are Suffering Due to Lack of Genetic Testing
There is a gene test that can help prevent and treat ovarian cancer with more success. This test is known as the BRCA gene test, which identifies a mutation that results in a dysfunctional enzyme whose job it to correct DNA mutations.Because cancer is due to mutations leading to unchecked tumor...
Nearby Providers
- Dr. Vijay K. Gandhi M.D.333 COTTMAN AVE PHILADELPHIA PA 19111
- Dr. Crystal S. Denlinger M.D.333 COTTMAN AVE PHILADELPHIA PA 19111
- Eiko Klimant201 West Evergreen Avenue Philadelphia Pennsylvania 19118
- Dr. Margaret Von-mehren M.D.7600 Central Ave Philadelphia PA 19111
- Barbara A Burtness M.D.333 Cottman Ave Philadelphia PA 19111
- Dr. Paul F Engstrom M.D.7600 Central Ave Philadelphia PA 19111